CA1257331A - Sonde a electrodes selectives d'ions - Google Patents

Sonde a electrodes selectives d'ions

Info

Publication number: CA1257331A
Authority: CA; Canada
Prior art keywords: ion; selective; sensor; sample; membrane
Prior art date: 1985-06-27
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

CA000512665A

Other languages

English (en)

Inventor

Gilbert Conover

John P. Willis

Thaddeus Minior

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

EOS TECHNOLOGY Corp

Original Assignee

EOS TECHNOLOGY Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-06-27

Filing date

1986-06-27

Publication date

1989-07-11

1986-06-27 Application filed by EOS TECHNOLOGY Corp filed Critical EOS TECHNOLOGY Corp

1989-07-11 Application granted granted Critical

1989-07-11 Publication of CA1257331A publication Critical patent/CA1257331A/fr

Status Expired legal-status Critical Current

Links

239000012528 membrane Substances 0.000 claims abstract description 190
102000004190 Enzymes Human genes 0.000 claims abstract description 57
108090000790 Enzymes Proteins 0.000 claims abstract description 56
230000000694 effects Effects 0.000 claims abstract description 48
239000011148 porous material Substances 0.000 claims abstract description 24
239000012925 reference material Substances 0.000 claims abstract description 17
239000000126 substance Substances 0.000 claims abstract description 11
150000002500 ions Chemical class 0.000 claims description 146
229940088598 enzyme Drugs 0.000 claims description 56
DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 claims description 34
-1 hydrogen ions Chemical class 0.000 claims description 33
239000000758 substrate Substances 0.000 claims description 32
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 27
230000000236 ionophoric effect Effects 0.000 claims description 25
239000000463 material Substances 0.000 claims description 25
239000002555 ionophore Substances 0.000 claims description 23
230000008859 change Effects 0.000 claims description 22
238000006243 chemical reaction Methods 0.000 claims description 19
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 18
229940109239 creatinine Drugs 0.000 claims description 17
GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 claims description 16
229920003023 plastic Polymers 0.000 claims description 16
239000004033 plastic Substances 0.000 claims description 16
239000004014 plasticizer Substances 0.000 claims description 15
239000011780 sodium chloride Substances 0.000 claims description 13
108010046334 Urease Proteins 0.000 claims description 12
229910001414 potassium ion Inorganic materials 0.000 claims description 12
239000001257 hydrogen Substances 0.000 claims description 11
229910052739 hydrogen Inorganic materials 0.000 claims description 11
102000016938 Catalase Human genes 0.000 claims description 10
108010053835 Catalase Proteins 0.000 claims description 10
NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 claims description 10
QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 9
239000004366 Glucose oxidase Substances 0.000 claims description 8
108010015776 Glucose oxidase Proteins 0.000 claims description 8
229940116332 glucose oxidase Drugs 0.000 claims description 8
235000019420 glucose oxidase Nutrition 0.000 claims description 8
108090001060 Lipase Proteins 0.000 claims description 7
239000004367 Lipase Substances 0.000 claims description 7
102000004882 Lipase Human genes 0.000 claims description 7
WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 7
235000019421 lipase Nutrition 0.000 claims description 7
229920005992 thermoplastic resin Polymers 0.000 claims description 7
239000007853 buffer solution Substances 0.000 claims description 6
CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 claims description 6
229910052709 silver Inorganic materials 0.000 claims description 6
239000004332 silver Substances 0.000 claims description 6
229910001415 sodium ion Inorganic materials 0.000 claims description 6
239000004677 Nylon Substances 0.000 claims description 5
229910021607 Silver chloride Inorganic materials 0.000 claims description 5
238000006911 enzymatic reaction Methods 0.000 claims description 5
229920001778 nylon Polymers 0.000 claims description 5
HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 claims description 5
FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 claims description 4
108010092464 Urate Oxidase Proteins 0.000 claims description 4
229960003624 creatine Drugs 0.000 claims description 3
239000006046 creatine Substances 0.000 claims description 3
229920000728 polyester Polymers 0.000 claims description 3
239000001103 potassium chloride Substances 0.000 claims description 3
235000011164 potassium chloride Nutrition 0.000 claims description 3
229920002472 Starch Polymers 0.000 claims description 2
229940032147 starch Drugs 0.000 claims description 2
239000008107 starch Substances 0.000 claims description 2
235000019698 starch Nutrition 0.000 claims description 2
230000013011 mating Effects 0.000 claims 6
BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 claims 1
BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims 1
BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims 1
QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 claims 1
QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 claims 1
125000003412 L-alanyl group Chemical group [H]N([H])[C@@](C([H])([H])[H])(C(=O)[*])[H] 0.000 claims 1
229960003767 alanine Drugs 0.000 claims 1
229910001424 calcium ion Inorganic materials 0.000 claims 1
150000002431 hydrogen Chemical class 0.000 claims 1
210000004379 membrane Anatomy 0.000 abstract description 169
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 abstract description 45
239000004202 carbamide Substances 0.000 abstract description 23
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 22
239000008103 glucose Substances 0.000 abstract description 22
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract description 10
150000003626 triacylglycerols Chemical class 0.000 abstract description 8
229940079593 drug Drugs 0.000 abstract description 6
239000003814 drug Substances 0.000 abstract description 6
239000000523 sample Substances 0.000 description 69
239000000243 solution Substances 0.000 description 62
ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 56
239000000306 component Substances 0.000 description 36
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 30
238000000034 method Methods 0.000 description 30
238000005259 measurement Methods 0.000 description 29
229960000278 theophylline Drugs 0.000 description 28
RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 27
239000000203 mixture Substances 0.000 description 26
235000002639 sodium chloride Nutrition 0.000 description 26
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 24
239000004800 polyvinyl chloride Substances 0.000 description 22
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 21
238000002360 preparation method Methods 0.000 description 21
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 20
210000004027 cell Anatomy 0.000 description 20
229920000915 polyvinyl chloride Polymers 0.000 description 20
150000001875 compounds Chemical class 0.000 description 19
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 18
229910001868 water Inorganic materials 0.000 description 17
JSGHQDAEHDRLOI-UHFFFAOYSA-N oxomalononitrile Chemical compound N#CC(=O)C#N JSGHQDAEHDRLOI-UHFFFAOYSA-N 0.000 description 16
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
239000007788 liquid Substances 0.000 description 15
230000004044 response Effects 0.000 description 15
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 14
LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 14
229960001948 caffeine Drugs 0.000 description 14
VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 14
150000003839 salts Chemical class 0.000 description 14
229910052700 potassium Inorganic materials 0.000 description 13
239000011541 reaction mixture Substances 0.000 description 13
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 12
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
239000000427 antigen Substances 0.000 description 12
102000036639 antigens Human genes 0.000 description 12
108091007433 antigens Proteins 0.000 description 12
239000000562 conjugate Substances 0.000 description 12
239000011521 glass Substances 0.000 description 12
239000011591 potassium Substances 0.000 description 12
235000007686 potassium Nutrition 0.000 description 12
229960003975 potassium Drugs 0.000 description 12
239000011734 sodium Substances 0.000 description 12
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 12
238000007792 addition Methods 0.000 description 11
238000012360 testing method Methods 0.000 description 11
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 10
239000001569 carbon dioxide Substances 0.000 description 10
229910002092 carbon dioxide Inorganic materials 0.000 description 10
229910052708 sodium Inorganic materials 0.000 description 10
238000000807 solvent casting Methods 0.000 description 10
QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 9
239000000020 Nitrocellulose Substances 0.000 description 9
FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 9
238000004458 analytical method Methods 0.000 description 9
239000013060 biological fluid Substances 0.000 description 9
229920001220 nitrocellulos Polymers 0.000 description 9
229940079938 nitrocellulose Drugs 0.000 description 9
108010082126 Alanine transaminase Proteins 0.000 description 8
108010003415 Aspartate Aminotransferases Proteins 0.000 description 8
102000004625 Aspartate Aminotransferases Human genes 0.000 description 8
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 8
239000002253 acid Substances 0.000 description 8
239000012491 analyte Substances 0.000 description 8
238000003618 dip coating Methods 0.000 description 8
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 8
230000002209 hydrophobic effect Effects 0.000 description 8
238000004519 manufacturing process Methods 0.000 description 8
238000001139 pH measurement Methods 0.000 description 8
239000002953 phosphate buffered saline Substances 0.000 description 8
210000002966 serum Anatomy 0.000 description 8
229960002668 sodium chloride Drugs 0.000 description 8
CXVOIIMJZFREMM-UHFFFAOYSA-N 1-(2-nitrophenoxy)octane Chemical group CCCCCCCCOC1=CC=CC=C1[N+]([O-])=O CXVOIIMJZFREMM-UHFFFAOYSA-N 0.000 description 7
102100036475 Alanine aminotransferase 1 Human genes 0.000 description 7
102000005548 Hexokinase Human genes 0.000 description 7
108700040460 Hexokinases Proteins 0.000 description 7
LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 7
TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 7
210000004369 blood Anatomy 0.000 description 7
239000008280 blood Substances 0.000 description 7
238000001704 evaporation Methods 0.000 description 7
230000008020 evaporation Effects 0.000 description 7
229910052751 metal Inorganic materials 0.000 description 7
239000002184 metal Substances 0.000 description 7
229920000642 polymer Polymers 0.000 description 7
239000000047 product Substances 0.000 description 7
230000035945 sensitivity Effects 0.000 description 7
229940116269 uric acid Drugs 0.000 description 7
LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 6
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 6
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 6
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
239000007864 aqueous solution Substances 0.000 description 6
150000001638 boron Chemical class 0.000 description 6
238000005342 ion exchange Methods 0.000 description 6
229940040461 lipase Drugs 0.000 description 6
238000000691 measurement method Methods 0.000 description 6
210000002381 plasma Anatomy 0.000 description 6
229920006395 saturated elastomer Polymers 0.000 description 6
239000007787 solid Substances 0.000 description 6
239000002904 solvent Substances 0.000 description 6
238000003786 synthesis reaction Methods 0.000 description 6
VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 5
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 5
ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 5
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 5
238000013494 PH determination Methods 0.000 description 5
239000002585 base Substances 0.000 description 5
230000015572 biosynthetic process Effects 0.000 description 5
229910052796 boron Inorganic materials 0.000 description 5
239000000872 buffer Substances 0.000 description 5
239000011575 calcium Substances 0.000 description 5
150000001768 cations Chemical class 0.000 description 5
230000003247 decreasing effect Effects 0.000 description 5
238000004090 dissolution Methods 0.000 description 5
229960005309 estradiol Drugs 0.000 description 5
229930182833 estradiol Natural products 0.000 description 5
238000009472 formulation Methods 0.000 description 5
230000006870 function Effects 0.000 description 5
238000003018 immunoassay Methods 0.000 description 5
239000003960 organic solvent Substances 0.000 description 5
238000002791 soaking Methods 0.000 description 5
239000004094 surface-active agent Substances 0.000 description 5
QUNWUDVFRNGTCO-UHFFFAOYSA-N 1,7-dimethylxanthine Chemical group N1C(=O)N(C)C(=O)C2=C1N=CN2C QUNWUDVFRNGTCO-UHFFFAOYSA-N 0.000 description 4
IVLXQGJVBGMLRR-UHFFFAOYSA-N 2-aminoacetic acid;hydron;chloride Chemical compound Cl.NCC(O)=O IVLXQGJVBGMLRR-UHFFFAOYSA-N 0.000 description 4
QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 4
102000002260 Alkaline Phosphatase Human genes 0.000 description 4
108020004774 Alkaline Phosphatase Proteins 0.000 description 4
CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
108010067973 Valinomycin Proteins 0.000 description 4
125000001931 aliphatic group Chemical group 0.000 description 4
125000000217 alkyl group Chemical group 0.000 description 4
102000013529 alpha-Fetoproteins Human genes 0.000 description 4
108010026331 alpha-Fetoproteins Proteins 0.000 description 4
150000001412 amines Chemical class 0.000 description 4
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
230000004888 barrier function Effects 0.000 description 4
229920002301 cellulose acetate Polymers 0.000 description 4
GTKRFUAGOKINCA-UHFFFAOYSA-M chlorosilver;silver Chemical compound [Ag].[Ag]Cl GTKRFUAGOKINCA-UHFFFAOYSA-M 0.000 description 4
230000009137 competitive binding Effects 0.000 description 4
FCFNRCROJUBPLU-UHFFFAOYSA-N compound M126 Natural products CC(C)C1NC(=O)C(C)OC(=O)C(C(C)C)NC(=O)C(C(C)C)OC(=O)C(C(C)C)NC(=O)C(C)OC(=O)C(C(C)C)NC(=O)C(C(C)C)OC(=O)C(C(C)C)NC(=O)C(C)OC(=O)C(C(C)C)NC(=O)C(C(C)C)OC1=O FCFNRCROJUBPLU-UHFFFAOYSA-N 0.000 description 4
239000000470 constituent Substances 0.000 description 4
229940093499 ethyl acetate Drugs 0.000 description 4
235000019439 ethyl acetate Nutrition 0.000 description 4
229960001269 glycine hydrochloride Drugs 0.000 description 4
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
230000007935 neutral effect Effects 0.000 description 4
229910052760 oxygen Inorganic materials 0.000 description 4
239000001301 oxygen Substances 0.000 description 4
238000011160 research Methods 0.000 description 4
235000017557 sodium bicarbonate Nutrition 0.000 description 4
229910000030 sodium bicarbonate Inorganic materials 0.000 description 4
FCFNRCROJUBPLU-DNDCDFAISA-N valinomycin Chemical group CC(C)[C@@H]1NC(=O)[C@H](C)OC(=O)[C@@H](C(C)C)NC(=O)[C@@H](C(C)C)OC(=O)[C@H](C(C)C)NC(=O)[C@H](C)OC(=O)[C@@H](C(C)C)NC(=O)[C@@H](C(C)C)OC(=O)[C@H](C(C)C)NC(=O)[C@H](C)OC(=O)[C@@H](C(C)C)NC(=O)[C@@H](C(C)C)OC1=O FCFNRCROJUBPLU-DNDCDFAISA-N 0.000 description 4
229920001817 Agar Polymers 0.000 description 3
239000004382 Amylase Substances 0.000 description 3
102000013142 Amylases Human genes 0.000 description 3
108010065511 Amylases Proteins 0.000 description 3
BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 3
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
102000004420 Creatine Kinase Human genes 0.000 description 3
108010042126 Creatine kinase Proteins 0.000 description 3
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
108010093096 Immobilized Enzymes Proteins 0.000 description 3
NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 3
UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 3
239000004698 Polyethylene Substances 0.000 description 3
239000004743 Polypropylene Substances 0.000 description 3
239000008272 agar Substances 0.000 description 3
235000019418 amylase Nutrition 0.000 description 3
238000013459 approach Methods 0.000 description 3
238000003556 assay Methods 0.000 description 3
229910052791 calcium Inorganic materials 0.000 description 3
125000004432 carbon atom Chemical group C* 0.000 description 3
150000003983 crown ethers Chemical group 0.000 description 3
238000011049 filling Methods 0.000 description 3
239000000706 filtrate Substances 0.000 description 3
238000001914 filtration Methods 0.000 description 3
239000007789 gas Substances 0.000 description 3
230000000984 immunochemical effect Effects 0.000 description 3
239000003550 marker Substances 0.000 description 3
GAOZTHIDHYLHMS-KEOBGNEYSA-N monensin A Chemical compound C([C@@](O1)(C)[C@H]2CC[C@@](O2)(CC)[C@H]2[C@H](C[C@@H](O2)[C@@H]2[C@H](C[C@@H](C)[C@](O)(CO)O2)C)C)C[C@@]21C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H](OC)[C@H](C)C(O)=O)O2 GAOZTHIDHYLHMS-KEOBGNEYSA-N 0.000 description 3
229920000573 polyethylene Polymers 0.000 description 3
229920001155 polypropylene Polymers 0.000 description 3
230000009257 reactivity Effects 0.000 description 3
239000012088 reference solution Substances 0.000 description 3
239000012488 sample solution Substances 0.000 description 3
238000003756 stirring Methods 0.000 description 3
238000003860 storage Methods 0.000 description 3
210000002700 urine Anatomy 0.000 description 3
229940075420 xanthine Drugs 0.000 description 3
RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
VFTFKUDGYRBSAL-UHFFFAOYSA-N 15-crown-5 Chemical compound C1COCCOCCOCCOCCO1 VFTFKUDGYRBSAL-UHFFFAOYSA-N 0.000 description 2
CQNGAZMLFIMLQN-UHFFFAOYSA-N 2,5,8,11,14-pentaoxabicyclo[13.4.0]nonadeca-1(15),16,18-trien-17-amine Chemical compound O1CCOCCOCCOCCOC2=CC(N)=CC=C21 CQNGAZMLFIMLQN-UHFFFAOYSA-N 0.000 description 2
OAJNZFCPJVBYHB-UHFFFAOYSA-N 2,5,8,11-tetraoxabicyclo[10.4.0]hexadeca-1(16),12,14-triene Chemical class O1CCOCCOCCOC2=CC=CC=C21 OAJNZFCPJVBYHB-UHFFFAOYSA-N 0.000 description 2
PLAZTCDQAHEYBI-UHFFFAOYSA-N 2-nitrotoluene Chemical compound CC1=CC=CC=C1[N+]([O-])=O PLAZTCDQAHEYBI-UHFFFAOYSA-N 0.000 description 2
RTGHRDFWYQHVFW-UHFFFAOYSA-N 3-oxoadipic acid Chemical compound OC(=O)CCC(=O)CC(O)=O RTGHRDFWYQHVFW-UHFFFAOYSA-N 0.000 description 2
229920000936 Agarose Polymers 0.000 description 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 description 2
GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 2
RMIXHJPMNBXMBU-QIIXEHPYSA-N Nonactin Chemical compound C[C@H]([C@H]1CC[C@H](O1)C[C@@H](OC(=O)[C@@H](C)[C@@H]1CC[C@@H](O1)C[C@@H](C)OC(=O)[C@H](C)[C@H]1CC[C@H](O1)C[C@H](C)OC(=O)[C@H]1C)C)C(=O)O[C@H](C)C[C@H]2CC[C@@H]1O2 RMIXHJPMNBXMBU-QIIXEHPYSA-N 0.000 description 2
RMIXHJPMNBXMBU-UHFFFAOYSA-N Nonactin Natural products CC1C(=O)OC(C)CC(O2)CCC2C(C)C(=O)OC(C)CC(O2)CCC2C(C)C(=O)OC(C)CC(O2)CCC2C(C)C(=O)OC(C)CC2CCC1O2 RMIXHJPMNBXMBU-UHFFFAOYSA-N 0.000 description 2
KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
239000007983 Tris buffer Substances 0.000 description 2
229960000583 acetic acid Drugs 0.000 description 2
125000003545 alkoxy group Chemical group 0.000 description 2
POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
229910021529 ammonia Inorganic materials 0.000 description 2
150000008378 aryl ethers Chemical class 0.000 description 2
230000008901 benefit Effects 0.000 description 2
FNEPSTUXZLEUCK-UHFFFAOYSA-N benzo-15-crown-5 Chemical compound O1CCOCCOCCOCCOC2=CC=CC=C21 FNEPSTUXZLEUCK-UHFFFAOYSA-N 0.000 description 2
230000027455 binding Effects 0.000 description 2
239000012472 biological sample Substances 0.000 description 2
229910052799 carbon Inorganic materials 0.000 description 2
239000000969 carrier Substances 0.000 description 2
210000001175 cerebrospinal fluid Anatomy 0.000 description 2
239000003610 charcoal Substances 0.000 description 2
238000005352 clarification Methods 0.000 description 2
239000004020 conductor Substances 0.000 description 2
238000011161 development Methods 0.000 description 2
238000000502 dialysis Methods 0.000 description 2
LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 description 2
229960005156 digoxin Drugs 0.000 description 2
LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 description 2
238000010790 dilution Methods 0.000 description 2
239000012895 dilution Substances 0.000 description 2
VJHINFRRDQUWOJ-UHFFFAOYSA-N dioctyl sebacate Chemical compound CCCCC(CC)COC(=O)CCCCCCCCC(=O)OCC(CC)CCCC VJHINFRRDQUWOJ-UHFFFAOYSA-N 0.000 description 2
239000003792 electrolyte Substances 0.000 description 2
DOWFOZZKCXFCOH-UHFFFAOYSA-N ethyl 3-nitro-4-octadecoxybenzoate Chemical compound CCCCCCCCCCCCCCCCCCOC1=CC=C(C(=O)OCC)C=C1[N+]([O-])=O DOWFOZZKCXFCOH-UHFFFAOYSA-N 0.000 description 2
239000010408 film Substances 0.000 description 2
239000000499 gel Substances 0.000 description 2
239000003349 gelling agent Substances 0.000 description 2
239000012362 glacial acetic acid Substances 0.000 description 2
229910052736 halogen Inorganic materials 0.000 description 2
150000002367 halogens Chemical class 0.000 description 2
125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 2
INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
125000000468 ketone group Chemical group 0.000 description 2
239000011159 matrix material Substances 0.000 description 2
XKBGEWXEAPTVCK-UHFFFAOYSA-M methyltrioctylammonium chloride Chemical compound [Cl-].CCCCCCCC[N+](C)(CCCCCCCC)CCCCCCCC XKBGEWXEAPTVCK-UHFFFAOYSA-M 0.000 description 2
238000002156 mixing Methods 0.000 description 2
235000019799 monosodium phosphate Nutrition 0.000 description 2
229910017604 nitric acid Inorganic materials 0.000 description 2
150000002828 nitro derivatives Chemical class 0.000 description 2
239000012811 non-conductive material Substances 0.000 description 2
230000010627 oxidative phosphorylation Effects 0.000 description 2
125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 2
239000013610 patient sample Substances 0.000 description 2
239000012071 phase Substances 0.000 description 2
239000011118 polyvinyl acetate Substances 0.000 description 2
229940075065 polyvinyl acetate Drugs 0.000 description 2
BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
239000002244 precipitate Substances 0.000 description 2
238000001556 precipitation Methods 0.000 description 2
238000012545 processing Methods 0.000 description 2
239000012460 protein solution Substances 0.000 description 2
230000002829 reductive effect Effects 0.000 description 2
239000013074 reference sample Substances 0.000 description 2
238000002390 rotary evaporation Methods 0.000 description 2
210000003296 saliva Anatomy 0.000 description 2
229920002379 silicone rubber Polymers 0.000 description 2
239000004945 silicone rubber Substances 0.000 description 2
AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 2
LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
229910000162 sodium phosphate Inorganic materials 0.000 description 2
159000000000 sodium salts Chemical class 0.000 description 2
239000007790 solid phase Substances 0.000 description 2
238000001228 spectrum Methods 0.000 description 2
230000001052 transient effect Effects 0.000 description 2
SWZDQOUHBYYPJD-UHFFFAOYSA-N tridodecylamine Chemical compound CCCCCCCCCCCCN(CCCCCCCCCCCC)CCCCCCCCCCCC SWZDQOUHBYYPJD-UHFFFAOYSA-N 0.000 description 2
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
238000010792 warming Methods 0.000 description 2
239000000080 wetting agent Substances 0.000 description 2
JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical class OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
PVLNHYPAZWPHDM-UHFFFAOYSA-N (4-chlorophenyl)boron Chemical compound [B]C1=CC=C(Cl)C=C1 PVLNHYPAZWPHDM-UHFFFAOYSA-N 0.000 description 1
DRKFWQDBPGTSOO-UHFFFAOYSA-N 1-methyl-2-nitro-4-propan-2-ylbenzene Chemical compound CC(C)C1=CC=C(C)C([N+]([O-])=O)=C1 DRKFWQDBPGTSOO-UHFFFAOYSA-N 0.000 description 1
UFBJCMHMOXMLKC-UHFFFAOYSA-N 2,4-dinitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O UFBJCMHMOXMLKC-UHFFFAOYSA-N 0.000 description 1
IEQAICDLOKRSRL-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO IEQAICDLOKRSRL-UHFFFAOYSA-N 0.000 description 1
NXWPOAQQKBBSFS-UHFFFAOYSA-N 2-aminoacetic acid;hydrochloride Chemical compound Cl.NCC(O)=O.NCC(O)=O NXWPOAQQKBBSFS-UHFFFAOYSA-N 0.000 description 1
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
102100021580 Active regulator of SIRT1 Human genes 0.000 description 1
102000009027 Albumins Human genes 0.000 description 1
108010088751 Albumins Proteins 0.000 description 1
POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
229910000497 Amalgam Inorganic materials 0.000 description 1
102100038916 Caspase-5 Human genes 0.000 description 1
229920002284 Cellulose triacetate Polymers 0.000 description 1
108010035722 Chloride peroxidase Proteins 0.000 description 1
NBSCHQHZLSJFNQ-GASJEMHNSA-N D-Glucose 6-phosphate Chemical compound OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O NBSCHQHZLSJFNQ-GASJEMHNSA-N 0.000 description 1
RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
241000255925 Diptera Species 0.000 description 1
238000002965 ELISA Methods 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
VFRROHXSMXFLSN-UHFFFAOYSA-N Glc6P Natural products OP(=O)(O)OCC(O)C(O)C(O)C(O)C=O VFRROHXSMXFLSN-UHFFFAOYSA-N 0.000 description 1
102000006395 Globulins Human genes 0.000 description 1
108010044091 Globulins Proteins 0.000 description 1
RGHNJXZEOKUKBD-SQOUGZDYSA-N Gluconic acid Natural products OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 1
229910004373 HOAc Inorganic materials 0.000 description 1
101100112336 Homo sapiens CASP5 gene Proteins 0.000 description 1
238000007375 Jaffe assay Methods 0.000 description 1
239000005909 Kieselgur Substances 0.000 description 1
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
241001024304 Mino Species 0.000 description 1
229930191564 Monensin Natural products 0.000 description 1
GAOZTHIDHYLHMS-UHFFFAOYSA-N Monensin A Natural products O1C(CC)(C2C(CC(O2)C2C(CC(C)C(O)(CO)O2)C)C)CCC1C(O1)(C)CCC21CC(O)C(C)C(C(C)C(OC)C(C)C(O)=O)O2 GAOZTHIDHYLHMS-UHFFFAOYSA-N 0.000 description 1
101100273286 Mus musculus Casp4 gene Proteins 0.000 description 1
206010028980 Neoplasm Diseases 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
239000002033 PVDF binder Substances 0.000 description 1
229930182555 Penicillin Natural products 0.000 description 1
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
108010087702 Penicillinase Proteins 0.000 description 1
102000003992 Peroxidases Human genes 0.000 description 1
108091000080 Phosphotransferase Proteins 0.000 description 1
229920001213 Polysorbate 20 Polymers 0.000 description 1
229920001214 Polysorbate 60 Polymers 0.000 description 1
101150026963 RPS19BP1 gene Proteins 0.000 description 1
239000007868 Raney catalyst Substances 0.000 description 1
NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
229910000564 Raney nickel Inorganic materials 0.000 description 1
208000036366 Sensation of pressure Diseases 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
239000004809 Teflon Substances 0.000 description 1
229920006362 Teflon® Polymers 0.000 description 1
RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 1
239000013504 Triton X-100 Substances 0.000 description 1
229920004890 Triton X-100 Polymers 0.000 description 1
NNLVGZFZQQXQNW-ADJNRHBOSA-N [(2r,3r,4s,5r,6s)-4,5-diacetyloxy-3-[(2s,3r,4s,5r,6r)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6s)-4,5,6-triacetyloxy-2-(acetyloxymethyl)oxan-3-yl]oxyoxan-2-yl]methyl acetate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](OC(C)=O)[C@H]1OC(C)=O)O[C@H]1[C@@H]([C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](COC(C)=O)O1)OC(C)=O)COC(=O)C)[C@@H]1[C@@H](COC(C)=O)O[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O NNLVGZFZQQXQNW-ADJNRHBOSA-N 0.000 description 1
229940022663 acetate Drugs 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical class OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 1
230000002411 adverse Effects 0.000 description 1
239000003513 alkali Substances 0.000 description 1
239000012670 alkaline solution Substances 0.000 description 1
230000029936 alkylation Effects 0.000 description 1
238000005804 alkylation reaction Methods 0.000 description 1
229960000458 allantoin Drugs 0.000 description 1
229940024606 amino acid Drugs 0.000 description 1
235000001014 amino acid Nutrition 0.000 description 1
150000001413 amino acids Chemical class 0.000 description 1
125000003277 amino group Chemical group 0.000 description 1
125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
150000001450 anions Chemical class 0.000 description 1
125000003118 aryl group Chemical group 0.000 description 1
239000003637 basic solution Substances 0.000 description 1
125000005605 benzo group Chemical group 0.000 description 1
235000013361 beverage Nutrition 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
KMTMVXCFWHJTEX-CCAGOZQPSA-N bis[(Z)-18,18-dibromooctadec-9-enyl] hydrogen phosphate Chemical compound C(CCC/C=C\CCCCCCCC(Br)Br)CCCCOP(=O)(OCCCCCCCC/C=C\CCCCCCCC(Br)Br)O KMTMVXCFWHJTEX-CCAGOZQPSA-N 0.000 description 1
230000000903 blocking effect Effects 0.000 description 1
238000009534 blood test Methods 0.000 description 1
239000005388 borosilicate glass Substances 0.000 description 1
229910052794 bromium Inorganic materials 0.000 description 1
239000008366 buffered solution Substances 0.000 description 1
DQXBYHZEEUGOBF-UHFFFAOYSA-N but-3-enoic acid;ethene Chemical compound C=C.OC(=O)CC=C DQXBYHZEEUGOBF-UHFFFAOYSA-N 0.000 description 1
OQDFUBYKRDYKBL-UHFFFAOYSA-N butyl-[2-oxo-2-(1-phenoxypropan-2-ylamino)ethyl]azanium;chloride Chemical compound [Cl-].CCCC[NH2+]CC(=O)NC(C)COC1=CC=CC=C1 OQDFUBYKRDYKBL-UHFFFAOYSA-N 0.000 description 1
159000000007 calcium salts Chemical class 0.000 description 1
239000003054 catalyst Substances 0.000 description 1
238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
238000006555 catalytic reaction Methods 0.000 description 1
239000003093 cationic surfactant Substances 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
230000005591 charge neutralization Effects 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
150000003841 chloride salts Chemical class 0.000 description 1
229910052801 chlorine Inorganic materials 0.000 description 1
239000002026 chloroform extract Substances 0.000 description 1
GGRHYQCXXYLUTL-UHFFFAOYSA-N chloromethyl 2,2-dimethylpropanoate Chemical compound CC(C)(C)C(=O)OCCl GGRHYQCXXYLUTL-UHFFFAOYSA-N 0.000 description 1
230000001684 chronic effect Effects 0.000 description 1
238000000576 coating method Methods 0.000 description 1
229940000425 combination drug Drugs 0.000 description 1
238000012875 competitive assay Methods 0.000 description 1
238000013329 compounding Methods 0.000 description 1
230000001143 conditioned effect Effects 0.000 description 1
238000001816 cooling Methods 0.000 description 1
239000007799 cork Substances 0.000 description 1
108010029444 creatinine deiminase Proteins 0.000 description 1
238000004132 cross linking Methods 0.000 description 1
230000009260 cross reactivity Effects 0.000 description 1
238000002425 crystallisation Methods 0.000 description 1
230000008025 crystallization Effects 0.000 description 1
NNTABFLZUGSQKW-UHFFFAOYSA-N ctk0h9052 Chemical compound NP(N)(Cl)=O NNTABFLZUGSQKW-UHFFFAOYSA-N 0.000 description 1
238000005520 cutting process Methods 0.000 description 1
125000004122 cyclic group Chemical group 0.000 description 1
238000004925 denaturation Methods 0.000 description 1
230000036425 denaturation Effects 0.000 description 1
150000005690 diesters Chemical class 0.000 description 1
235000014113 dietary fatty acids Nutrition 0.000 description 1
238000009792 diffusion process Methods 0.000 description 1
ZOMNIUBKTOKEHS-UHFFFAOYSA-L dimercury dichloride Chemical class Cl[Hg][Hg]Cl ZOMNIUBKTOKEHS-UHFFFAOYSA-L 0.000 description 1
230000003292 diminished effect Effects 0.000 description 1
HAKMAMKAFTZXOZ-UHFFFAOYSA-N dioctoxyphosphorylbenzene Chemical compound CCCCCCCCOP(=O)(OCCCCCCCC)C1=CC=CC=C1 HAKMAMKAFTZXOZ-UHFFFAOYSA-N 0.000 description 1
238000007598 dipping method Methods 0.000 description 1
230000002183 duodenal effect Effects 0.000 description 1
229920001971 elastomer Polymers 0.000 description 1
239000000806 elastomer Substances 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
125000004185 ester group Chemical group 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
NIPNPMUJWJSXTE-UHFFFAOYSA-N ethyl 3-amino-4-octadecoxybenzoate Chemical compound CCCCCCCCCCCCCCCCCCOC1=CC=C(C(=O)OCC)C=C1N NIPNPMUJWJSXTE-UHFFFAOYSA-N 0.000 description 1
FBHJNBWUGONVNS-UHFFFAOYSA-N ethyl 4-hydroxy-3-nitrobenzoate Chemical compound CCOC(=O)C1=CC=C(O)C([N+]([O-])=O)=C1 FBHJNBWUGONVNS-UHFFFAOYSA-N 0.000 description 1
OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 1
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
239000005038 ethylene vinyl acetate Substances 0.000 description 1
239000000284 extract Substances 0.000 description 1
239000000194 fatty acid Substances 0.000 description 1
229930195729 fatty acid Natural products 0.000 description 1
150000004665 fatty acids Chemical class 0.000 description 1
239000000835 fiber Substances 0.000 description 1
239000012530 fluid Substances 0.000 description 1
229910052731 fluorine Inorganic materials 0.000 description 1
229940068517 fruit extracts Drugs 0.000 description 1
235000011389 fruit/vegetable juice Nutrition 0.000 description 1
239000003517 fume Substances 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
239000003365 glass fiber Substances 0.000 description 1
239000000174 gluconic acid Substances 0.000 description 1
235000012208 gluconic acid Nutrition 0.000 description 1
208000006454 hepatitis Diseases 0.000 description 1
231100000283 hepatitis Toxicity 0.000 description 1
238000004128 high performance liquid chromatography Methods 0.000 description 1
230000007062 hydrolysis Effects 0.000 description 1
238000006460 hydrolysis reaction Methods 0.000 description 1
230000005661 hydrophobic surface Effects 0.000 description 1
238000007654 immersion Methods 0.000 description 1
238000002513 implantation Methods 0.000 description 1
230000002779 inactivation Effects 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
239000002198 insoluble material Substances 0.000 description 1
XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 description 1
229940006461 iodide ion Drugs 0.000 description 1
238000002955 isolation Methods 0.000 description 1
150000002576 ketones Chemical class 0.000 description 1
230000003907 kidney function Effects 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
235000019626 lipase activity Nutrition 0.000 description 1
239000007791 liquid phase Substances 0.000 description 1
229910052744 lithium Inorganic materials 0.000 description 1
239000011654 magnesium acetate Substances 0.000 description 1
235000011285 magnesium acetate Nutrition 0.000 description 1
UEGPKNKPLBYCNK-UHFFFAOYSA-L magnesium acetate Chemical compound [Mg+2].CC([O-])=O.CC([O-])=O UEGPKNKPLBYCNK-UHFFFAOYSA-L 0.000 description 1
229940069446 magnesium acetate Drugs 0.000 description 1
229910001425 magnesium ion Inorganic materials 0.000 description 1
159000000003 magnesium salts Chemical class 0.000 description 1
238000003760 magnetic stirring Methods 0.000 description 1
CUONGYYJJVDODC-UHFFFAOYSA-N malononitrile Chemical compound N#CCC#N CUONGYYJJVDODC-UHFFFAOYSA-N 0.000 description 1
235000013372 meat Nutrition 0.000 description 1
239000002207 metabolite Substances 0.000 description 1
229910001507 metal halide Inorganic materials 0.000 description 1
150000005309 metal halides Chemical class 0.000 description 1
230000005012 migration Effects 0.000 description 1
238000013508 migration Methods 0.000 description 1
210000003470 mitochondria Anatomy 0.000 description 1
230000004048 modification Effects 0.000 description 1
238000012986 modification Methods 0.000 description 1
229960005358 monensin Drugs 0.000 description 1
238000006386 neutralization reaction Methods 0.000 description 1
PXHVJJICTQNCMI-UHFFFAOYSA-N nickel Substances [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 1
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
229910000069 nitrogen hydride Inorganic materials 0.000 description 1
239000002736 nonionic surfactant Substances 0.000 description 1
230000003647 oxidation Effects 0.000 description 1
238000007254 oxidation reaction Methods 0.000 description 1
229940049954 penicillin Drugs 0.000 description 1
229950009506 penicillinase Drugs 0.000 description 1
XNLICIUVMPYHGG-UHFFFAOYSA-N pentan-2-one Chemical compound CCCC(C)=O XNLICIUVMPYHGG-UHFFFAOYSA-N 0.000 description 1
230000035699 permeability Effects 0.000 description 1
108040007629 peroxidase activity proteins Proteins 0.000 description 1
ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
235000021317 phosphate Nutrition 0.000 description 1
235000011007 phosphoric acid Nutrition 0.000 description 1
150000003016 phosphoric acids Chemical class 0.000 description 1
230000026731 phosphorylation Effects 0.000 description 1
238000006366 phosphorylation reaction Methods 0.000 description 1
102000020233 phosphotransferase Human genes 0.000 description 1
230000035479 physiological effects, processes and functions Effects 0.000 description 1
229940075930 picrate Drugs 0.000 description 1
OXNIZHLAWKMVMX-UHFFFAOYSA-M picrate anion Chemical compound [O-]C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-M 0.000 description 1
108010020002 platelet endothelial cell activated protease Proteins 0.000 description 1
229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
229920000056 polyoxyethylene ether Polymers 0.000 description 1
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
229920001343 polytetrafluoroethylene Polymers 0.000 description 1
239000004810 polytetrafluoroethylene Substances 0.000 description 1
229920002689 polyvinyl acetate Polymers 0.000 description 1
229920002981 polyvinylidene fluoride Polymers 0.000 description 1
229910000027 potassium carbonate Inorganic materials 0.000 description 1
235000013324 preserved food Nutrition 0.000 description 1
SCUZVMOVTVSBLE-UHFFFAOYSA-N prop-2-enenitrile;styrene Chemical compound C=CC#N.C=CC1=CC=CC=C1 SCUZVMOVTVSBLE-UHFFFAOYSA-N 0.000 description 1
235000018102 proteins Nutrition 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
150000003242 quaternary ammonium salts Chemical class 0.000 description 1
BDJXVNRFAQSMAA-UHFFFAOYSA-N quinhydrone Chemical compound OC1=CC=C(O)C=C1.O=C1C=CC(=O)C=C1 BDJXVNRFAQSMAA-UHFFFAOYSA-N 0.000 description 1
229940052881 quinhydrone Drugs 0.000 description 1
230000009467 reduction Effects 0.000 description 1
235000021067 refined food Nutrition 0.000 description 1
238000010992 reflux Methods 0.000 description 1
239000004627 regenerated cellulose Substances 0.000 description 1
229920005989 resin Polymers 0.000 description 1
239000011347 resin Substances 0.000 description 1
238000001223 reverse osmosis Methods 0.000 description 1
CXMXRPHRNRROMY-UHFFFAOYSA-N sebacic acid Chemical class OC(=O)CCCCCCCCC(O)=O CXMXRPHRNRROMY-UHFFFAOYSA-N 0.000 description 1
RDZTWEVXRGYCFV-UHFFFAOYSA-M sodium 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonate Chemical compound [Na+].OCCN1CCN(CCS([O-])(=O)=O)CC1 RDZTWEVXRGYCFV-UHFFFAOYSA-M 0.000 description 1
229910000029 sodium carbonate Inorganic materials 0.000 description 1
235000010288 sodium nitrite Nutrition 0.000 description 1
229910052938 sodium sulfate Inorganic materials 0.000 description 1
235000011152 sodium sulphate Nutrition 0.000 description 1
XOIQMTLWECTKJL-FBZUZRIGSA-M sodium;(2s,3r,4s)-4-[(2s,5r,7s,8r,9s)-2-[(2r,5s)-5-ethyl-5-[(2r,3s,5r)-5-[(2s,3s,5r,6r)-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyloxan-2-yl]-3-methyloxolan-2-yl]oxolan-2-yl]-7-hydroxy-2,8-dimethyl-1,10-dioxaspiro[4.5]decan-9-yl]-3-methoxy-2-methylpentanoate Chemical compound [Na+].C([C@@](O1)(C)[C@H]2CC[C@@](O2)(CC)[C@H]2[C@H](C[C@@H](O2)[C@@H]2[C@H](C[C@@H](C)[C@](O)(CO)O2)C)C)C[C@@]21C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H](OC)[C@H](C)C([O-])=O)O2 XOIQMTLWECTKJL-FBZUZRIGSA-M 0.000 description 1
238000001179 sorption measurement Methods 0.000 description 1
241000894007 species Species 0.000 description 1
229920000638 styrene acrylonitrile Polymers 0.000 description 1
229910052717 sulfur Inorganic materials 0.000 description 1
230000002194 synthesizing effect Effects 0.000 description 1
230000002277 temperature effect Effects 0.000 description 1
150000003512 tertiary amines Chemical class 0.000 description 1
239000012085 test solution Substances 0.000 description 1
229920001169 thermoplastic Polymers 0.000 description 1
239000004416 thermosoftening plastic Substances 0.000 description 1
239000010409 thin film Substances 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1
WTLBZVNBAKMVDP-UHFFFAOYSA-N tris(2-butoxyethyl) phosphate Chemical compound CCCCOCCOP(=O)(OCCOCCCC)OCCOCCCC WTLBZVNBAKMVDP-UHFFFAOYSA-N 0.000 description 1
GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
238000000108 ultra-filtration Methods 0.000 description 1
238000003260 vortexing Methods 0.000 description 1
238000005406 washing Methods 0.000 description 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
- G01N33/492—Determining multiple analytes

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Chemical & Material Sciences (AREA)
Hematology (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Biochemistry (AREA)
Urology & Nephrology (AREA)
Ecology (AREA)
Food Science & Technology (AREA)
Medicinal Chemistry (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
General Health & Medical Sciences (AREA)
General Physics & Mathematics (AREA)
Immunology (AREA)
Pathology (AREA)
Investigating Or Analysing Biological Materials (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)

CA000512665A 1985-06-27 1986-06-27 Sonde a electrodes selectives d'ions Expired CA1257331A (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US75052585A	1985-06-27	1985-06-27
US750,525		1985-06-27

Publications (1)

Publication Number	Publication Date
CA1257331A true CA1257331A (fr)	1989-07-11

Family

ID=25018222

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA000512665A Expired CA1257331A (fr)	1985-06-27	1986-06-27	Sonde a electrodes selectives d'ions

Country Status (7)

Country	Link
EP (1)	EP0230449A1 (fr)
JP (1)	JPS63500539A (fr)
AU (1)	AU602868B2 (fr)
CA (1)	CA1257331A (fr)
DK (1)	DK98987A (fr)
IL (1)	IL79230A0 (fr)
WO (1)	WO1987000286A1 (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1988000708A1 (fr) *	1986-07-21	1988-01-28	Ilex Corporation	Analyseur utilise en chimie clinique
US4889613A (en) *	1987-09-11	1989-12-26	Beckman Instruments, Inc.	Analytical apparatus, electrode and sample container for use therewith
CA1307825C (fr) *	1987-12-09	1992-09-22	Michael H. Burnam	Methode et appareil pour l'analyse du sang par dosage unique
DK409188D0 (da) *	1988-07-21	1988-07-21	Radiometer As	Fremgangsmaade til maaling af en karakteristik i et fluidum
US5235526A (en) *	1990-11-27	1993-08-10	Solomat Limited	Multi-probed sonde including microprocessor
WO1995025953A1 (fr) *	1994-03-22	1995-09-28	Hans Opl	Capteur de controle de l'activite ionique dans les liquides biologiques
JP3595907B2 (ja) *	1996-06-21	2004-12-02	デイド、ベーリング、インコーポレイテッド	イオン選択性電極製造のための組成物および方法
WO1998019159A1 (fr)	1996-10-30	1998-05-07	Mercury Diagnostics, Inc.	Systeme d'essai synchronise de l'analysat
DE19747875A1 (de) *	1997-10-20	1999-05-06	Meinhard Prof Dr Knoll	Verfahren zum Messen veränderlicher Größen und Vorrichtung zum Durchführen des Verfahrens
DE69839771D1 (de) *	1998-10-09	2008-09-04	Asulab Sa	Einfach handzuhabender streifenförmiger elektrochemischer Sensor
US7810380B2 (en)	2003-03-25	2010-10-12	Tearlab Research, Inc.	Systems and methods for collecting tear film and measuring tear film osmolarity
US7905134B2 (en)	2002-08-06	2011-03-15	The Regents Of The University Of California	Biomarker normalization
JP4988581B2 (ja)	2004-10-12	2012-08-01	バイエル・ヘルスケア・エルエルシー	拡散隔膜レイヤーにおける濃度測定
PT2142905E (pt) *	2007-04-16	2013-04-23	Univ California	Normalização de marcador biológico
US9952174B2 (en)	2014-04-18	2018-04-24	Siemens Healthcare Diagnostics Inc.	Magnesium sensing membrane for potentiometric ion selective electrode for measuring ionized magnesium and methods of production and use thereof
JP6749848B2 (ja)	2014-06-12	2020-09-02	シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレーテッドＳｉｅｍｅｎｓＨｅａｌｔｈｃａｒｅＤｉａｇｎｏｓｔｉｃｓＩｎｃ．	電位差滴定マグネシウムイオン選択性電極センサのための試薬並びにその製造方法及び使用方法
BR112017005121A2 (pt)	2014-09-23	2018-07-31	Tearlab Res Inc	sistemas e métodos para integração de coleta de lágrima microfluídica e análise de fluxo lateral de analitos de interesse.
US9883827B2 (en)	2015-03-09	2018-02-06	CoreSyte, Inc.	System and method for measuring biological fluid biomarkers
US9645133B2 (en)	2015-03-09	2017-05-09	CoreSyte, Inc.	Method for manufacturing a biological fluid sensor
US9636061B2 (en)	2015-03-09	2017-05-02	CoreSyte, Inc.	System and method for measuring biological fluid biomarkers
US11389087B2 (en)	2015-03-09	2022-07-19	CoreSyte, Inc.	Device for measuring biological fluids
US10327676B2 (en)	2015-03-09	2019-06-25	CoreSyte, Inc.	Device for measuring biological fluids
US10561405B2 (en)	2015-03-09	2020-02-18	CoreSyte, Inc.	Method for manufacturing a biological fluid sensor
US9579024B2 (en)	2015-03-09	2017-02-28	CoreSyte, Inc.	System and method for measuring biological fluid biomarkers
US11883011B2 (en)	2015-03-09	2024-01-30	CoreSyte, Inc.	Method for manufacturing a biological fluid sensor
US11998319B2 (en)	2015-03-09	2024-06-04	CoreSyte, Inc.	Device for measuring biological fluids
US9622725B2 (en)	2015-03-09	2017-04-18	CoreSyte, Inc.	Method for manufacturing a biological fluid sensor
WO2016144529A1 (fr) *	2015-03-09	2016-09-15	CoreSyte, Inc.	Procédés de fabrication de dispositifs de type capteurs de fluides biologiques et dispositifs, systèmes, et procédés de mesure de fluides biologiques
US10925499B2 (en)	2017-03-02	2021-02-23	SP Global, Inc.	System and method for using integrated sensor arrays to measure and analyze multiple biosignatures in real time
EP3388825A1 (fr) *	2017-04-12	2018-10-17	Medizinische Universität Innsbruck	Capteur potentiometrique pour la détermination quantitative de la concentration de sodium et la concentration de créatinine
US11016074B2 (en) *	2018-03-29	2021-05-25	Ecowater Systems, Llc	Apparatus for measuring water hardness using ion selective electrode
EP4016068B1 (fr) *	2020-12-21	2025-03-05	F. Hoffmann-La Roche AG	Ensemble capteurs
CN121410077B (zh) *	2025-12-30	2026-04-07	四川省科源工程技术测试中心有限责任公司	基于电化学控制变量分析法的土壤成分测定装置

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4053381A (en) *	1976-05-19	1977-10-11	Eastman Kodak Company	Device for determining ionic activity of components of liquid drops
US4214968A (en) *	1978-04-05	1980-07-29	Eastman Kodak Company	Ion-selective electrode
US4225410A (en) *	1978-12-04	1980-09-30	Technicon Instruments Corporation	Integrated array of electrochemical sensors
US4273639A (en) *	1979-06-20	1981-06-16	Eastman Kodak Company	Capillary bridge in apparatus for determining ionic activity
US4413407A (en) *	1980-03-10	1983-11-08	Eastman Kodak Company	Method for forming an electrode-containing device with capillary transport between electrodes
JPS58140635A (ja) *	1982-02-16	1983-08-20	Fuji Photo Film Co Ltd	液体移送分配装置およびイオン活量測定器具

1986
- 1986-06-25 JP JP61503624A patent/JPS63500539A/ja active Pending
- 1986-06-25 AU AU61244/86A patent/AU602868B2/en not_active Expired - Fee Related
- 1986-06-25 IL IL79230A patent/IL79230A0/xx unknown
- 1986-06-25 EP EP86904582A patent/EP0230449A1/fr not_active Withdrawn
- 1986-06-25 WO PCT/US1986/001370 patent/WO1987000286A1/fr not_active Ceased
- 1986-06-27 CA CA000512665A patent/CA1257331A/fr not_active Expired
1987
- 1987-02-26 DK DK098987A patent/DK98987A/da not_active Application Discontinuation

Also Published As

Publication number	Publication date
AU602868B2 (en)	1990-11-01
DK98987D0 (da)	1987-02-26
JPS63500539A (ja)	1988-02-25
IL79230A0 (en)	1986-09-30
EP0230449A1 (fr)	1987-08-05
DK98987A (da)	1987-04-27
AU6124486A (en)	1987-01-30
WO1987000286A1 (fr)	1987-01-15

Legal Events

Date	Code	Title	Description
2006-07-11	MKEX	Expiry

Publication	Publication Date	Title
CA1257331A (fr)	1989-07-11	Sonde a electrodes selectives d'ions
US4713165A (en)	1987-12-15	Sensor having ion-selective electrodes
US6663756B2 (en)	2003-12-16	Microchip-type oxygen gas sensor based on differential potentiometry
US6037178A (en)	2000-03-14	Method for quality control of an analyzing system
US5286365A (en)	1994-02-15	Graphite-based solid state polymeric membrane ion-selective electrodes
EP1164372B1 (fr)	2010-03-03	Capteur différentiel de gaz dioxyde de carbone à base d'un microchip
US4171246A (en)	1979-10-16	Method for determining ionic activity of components of liquid drops
US20250258124A1 (en)	2025-08-14	Single-use disposable reference sensor
Alegret et al.	2007	Electrochemical sensor analysis
EP0759551B1 (fr)	2003-05-21	Capteur planaire de bicarbonate
US6197172B1 (en)	2001-03-06	Electrochemical sensor with gelled membrane and method of making
US4708776A (en)	1987-11-24	Sodium ion selective electrode and method of use
EP0341859A1 (fr)	1989-11-15	Compositions et électrodes sélectives aux ions lithium, et méthode d'utilisation
WO1987000168A2 (fr)	1987-01-15	Ionophores et membranes selectives aux ions contenant lesdits ionophores
JPS6097250A (ja)	1985-05-31	特定の酵素／イオン発生団対を使用する診断用電極膜
WO1993019361A1 (fr)	1993-09-30	Electrode et composition a selectivite phosphate
Vlasov et al.	1992	Analytical applications of pH-ISFETs
US20010051109A1 (en)	2001-12-13	Enzymatic analysis system
JP4662615B2 (ja)	2011-03-30	乾式操作型イオン選択性電極及び液体中のイオンの存在又は量の決定法
Gandhi et al.	2022	Potentiometry
JPH0943191A (ja)	1997-02-14	塩素イオンセンサ
JPH1010078A (ja)	1998-01-16	塩素イオンセンサ
Hulley	1988	Chemical sensors—an overview
Birch et al.	1988	Potentiometric transducers
JPH102876A (ja)	1998-01-06	塩素イオンセンサ